ResearcherThomas Jefferson UniversityActive in the last 2 years
Andre Alabd
Matched on ORCID iD 0000-0002-3307-5602; OpenAlex author ID A5033741703. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence. Co-author DOI 10.18632/oncotarget.28739↗
- Pancreatic Cancer-Associated Diabetes is Clinically Distinguishable From Conventional Diabetes. Co-author DOI 10.1016/j.jss.2020.12.015↗
- Elucidating the Causes of Improved Survival in Clinical Trials of Randomized Adjuvant Pancreatic Ductal Adenocarcinoma (PDAC). Co-author DOI 10.1245/s10434-020-08859-y↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jordan Michael Winter · 3 shared papers, 2021–2025 · strength 0.51
- Paper Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence. DOI 10.18632/oncotarget.28739↗
- Paper Pancreatic Cancer-Associated Diabetes is Clinically Distinguishable From Conventional Diabetes. DOI 10.1016/j.jss.2020.12.015↗
- Paper Elucidating the Causes of Improved Survival in Clinical Trials of Randomized Adjuvant Pancreatic Ductal Adenocarcinoma … DOI 10.1245/s10434-020-08859-y↗
- Kavin Sugumar · 2 shared papers, 2021–2025 · strength 0.36
- Paper Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence. DOI 10.18632/oncotarget.28739↗
- Paper Elucidating the Causes of Improved Survival in Clinical Trials of Randomized Adjuvant Pancreatic Ductal Adenocarcinoma … DOI 10.1245/s10434-020-08859-y↗
- Zev A. Wainberg · 1 shared paper, 2025 · strength 0.21
- Ashwin Reddy Sama · 1 shared paper, 2025 · strength 0.21
- Jonathan J. Hue · 1 shared paper, 2025 · strength 0.21
- Jason Scott Starr · 1 shared paper, 2025 · strength 0.21
- Anup Kasi · 1 shared paper, 2025 · strength 0.21
- Hedy Lee Kindler · 1 shared paper, 2025 · strength 0.21
- Lei Zheng · 1 shared paper, 2025 · strength 0.21
- Bo Hyung Yoon · 1 shared paper, 2021 · strength 0.15
- John Brian Ammori · 1 shared paper, 2021 · strength 0.15
- Jeffrey M. Hardacre · 1 shared paper, 2021 · strength 0.15
- Harish Lavu · 1 shared paper, 2021 · strength 0.15
- Charles J. Yeo · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.